176 related articles for article (PubMed ID: 19414924)
1. Nanoparticle imaging for genitourinary cancers.
Eisner BH; Feldman AS
Cancer Biomark; 2009; 5(2):75-9. PubMed ID: 19414924
[TBL] [Abstract][Full Text] [Related]
2. The potential of nanoparticle-enhanced imaging.
Feldman AS; McDougal WS; Harisinghani MG
Urol Oncol; 2008; 26(1):65-73. PubMed ID: 18190834
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of lymphotrophic nanoparticle-enhanced magnetic resonance imaging technique in early stage testicular cancer: a new method for noninvasive lymph node evaluation.
Harisinghani MG; Saksena M; Ross RW; Tabatabaei S; Dahl D; McDougal S; Weissleder R
Urology; 2005 Nov; 66(5):1066-71. PubMed ID: 16286125
[TBL] [Abstract][Full Text] [Related]
4. Nodal staging in genitourinary cancers.
Saksena MA; Kim JY; Harisinghani MG
Abdom Imaging; 2006; 31(6):644-51. PubMed ID: 16967256
[TBL] [Abstract][Full Text] [Related]
5. Lymphotropic nanoparticle enhanced MRI for the staging of genitourinary tumors.
Mouli SK; Zhao LC; Omary RA; Thaxton CS
Nat Rev Urol; 2010 Feb; 7(2):84-93. PubMed ID: 20084078
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging of the genitourinary tract.
Choyke PL
Curr Opin Radiol; 1992 Apr; 4(2):24-31. PubMed ID: 1554584
[TBL] [Abstract][Full Text] [Related]
7. [Value of imaging for lymph node metastases from renal cell, bladder, prostate, penile, and testicular cancers].
Stattaus J; Bockisch A; Forsting M; Müller SP
Urologe A; 2005 Jun; 44(6):614-24. PubMed ID: 15905989
[TBL] [Abstract][Full Text] [Related]
8. Iron oxide particle-enhanced magnetic resonance imaging for detection of benign lymph nodes in the head and neck: how reliable are the results?
Baghi M; Mack MG; Wagenblast J; Hambek M; Rieger J; Bisdas S; Gstoettner W; Engels K; Vogl T; Knecht R
Anticancer Res; 2007; 27(5B):3571-5. PubMed ID: 17972519
[TBL] [Abstract][Full Text] [Related]
9. Cellular magnetic resonance imaging using superparamagnetic anionic iron oxide nanoparticles: applications to in vivo trafficking of lymphocytes and cell-based anticancer therapy.
Smirnov P
Methods Mol Biol; 2009; 512():333-53. PubMed ID: 19347287
[TBL] [Abstract][Full Text] [Related]
10. Determination of nanoparticle vehicle unpackaging by MR imaging of a T(2) magnetic relaxation switch.
Park IK; Ng CP; Wang J; Chu B; Yuan C; Zhang S; Pun SH
Biomaterials; 2008 Feb; 29(6):724-32. PubMed ID: 18006052
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging of the genitourinary tract.
Haggar AM; Kressel HY
Urol Clin North Am; 1985 Nov; 12(4):725-36. PubMed ID: 3904125
[TBL] [Abstract][Full Text] [Related]
12. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
Lin JJ; Chen JS; Huang SJ; Ko JH; Wang YM; Chen TL; Wang LF
Biomaterials; 2009 Oct; 30(28):5114-24. PubMed ID: 19560199
[TBL] [Abstract][Full Text] [Related]
13. Chemical design of nanoparticle probes for high-performance magnetic resonance imaging.
Jun YW; Lee JH; Cheon J
Angew Chem Int Ed Engl; 2008; 47(28):5122-35. PubMed ID: 18574805
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle enhanced imaging.
Harisinghani MG
Cancer Biomark; 2009; 5(2):59. PubMed ID: 19414921
[No Abstract] [Full Text] [Related]
15. Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer.
Fortina P; Kricka LJ; Graves DJ; Park J; Hyslop T; Tam F; Halas N; Surrey S; Waldman SA
Trends Biotechnol; 2007 Apr; 25(4):145-52. PubMed ID: 17316852
[TBL] [Abstract][Full Text] [Related]
16. Imaging in genitourinary cancer from the urologists' perspective.
Tsakiris P; de la Rosette J
Cancer Imaging; 2007 May; 7(1):84-92. PubMed ID: 17535776
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging for axillary staging in patients with breast cancer.
Mortellaro VE; Marshall J; Singer L; Hochwald SN; Chang M; Copeland EM; Grobmyer SR
J Magn Reson Imaging; 2009 Aug; 30(2):309-12. PubMed ID: 19466713
[TBL] [Abstract][Full Text] [Related]
18. Follow-up surveillance strategies for genitourinary malignancies.
Evans CP
Cancer; 2002 Jun; 94(11):2892-905. PubMed ID: 12115377
[TBL] [Abstract][Full Text] [Related]
19. Current and proposed molecular diagnostics in a genitourinary service line laboratory at a tertiary clinical institution.
Udager AM; Alva A; Mehra R
Cancer J; 2014; 20(1):29-42. PubMed ID: 24445763
[TBL] [Abstract][Full Text] [Related]
20. MRI in uro and gynaecological cancer.
El-Diasty TA
Tunis Med; 2005 Dec; 83 Suppl 12():26-7. PubMed ID: 16430063
[No Abstract] [Full Text] [Related]
[Next] [New Search]
